Crypto Med Innovation, a South Korean biotech company today announced that it will trial its newly developed COVID-19 testing kits.
Online PR News – 02-September-2020 – Gangnam-gu/SEOUL – Crypto Med Innovation's newly developed COVID-19 test kit uses artificial intelligence and analyses and processes DNA from a patient and can confirm whether the person is infected with COVID-19 in 180 minutes.
Crypto Med Innovation’s Chief Operating Officer, Mr. William Harris said “The purpose of these new testing kits is to allow for a large number of tests to be conducted as quickly and as efficiently as possible. As the kit analyses certain genes related to COVID-19, we envisage a high level of accuracy and target detection. Our new test kit will evaluate samples collected from the nose, mouth, neck and tongue.”
"We are planning to supply our test kit to countries who need it the most, but first, we will need to test the kits development and accuracy, and only then we will look to manufacture first and as early as possible. Our long term aim is to monitor the test kit's performance to detect numerous mutations of coronavirus, but also detect and treat any new emerging viruses," added William Harris, Chief Operating Officer of Crypto Med Innovation.
About Us - Crypto Med Innovation
Based in South Korea’s capital city of Seoul, our mission here at Crypto Med Innovation is to transform the medical research field while providing personal health solutions through artificial intelligence and comprehensive data analysis. We aim to enable you to take control of your life by understanding your health, delivering vital information to allow healthcare professionals to deliver better-targeted care and treatment.
We at Crypto Med Innovation believe that information technology and artificial intelligence are the future and will propel humankind to new heights through better understanding. We aim to put your medical information in your hands and those who can provide effective healthcare solutions.